Found: 55
Select item for more details and to access through your institution.
EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 5, p. 737, doi. 10.1007/s00432-014-1626-2
- By:
- Publication type:
- Article
Safety and Tolerability of Anthracycline-Containing Adjuvant Chemotherapy in Elderly High-Risk Breast Cancer Patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Induction Chemotherapy with Cisplatin, Epirubicin, and Paclitaxel (CEP), Followed by Concomitant Radiotherapy and Weekly Paclitaxel for the Management of Locally Advanced Nasopharyngeal Carcinoma.
- Published in:
- Strahlentherapie und Onkologie, 2005, v. 181, n. 4, p. 223, doi. 10.1007/s00066-005-1355-1
- By:
- Publication type:
- Article
Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-Based Regimens.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1053, doi. 10.4143/crt.2021.748
- By:
- Publication type:
- Article
Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140293
- By:
- Publication type:
- Article
Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 198, doi. 10.3390/cancers13020198
- By:
- Publication type:
- Article
Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1907, doi. 10.3390/cancers12071907
- By:
- Publication type:
- Article
Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 158, n. 2, p. 307, doi. 10.1007/s10549-016-3883-z
- By:
- Publication type:
- Article
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 134, n. 1, p. 353, doi. 10.1007/s10549-012-2021-9
- By:
- Publication type:
- Article
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 132, n. 2, p. 609, doi. 10.1007/s10549-011-1913-4
- By:
- Publication type:
- Article
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 116, n. 1, p. 131, doi. 10.1007/s10549-008-0144-9
- By:
- Publication type:
- Article
Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early‐stage breast cancer patients treated with anthracycline‐based adjuvant chemotherapy.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 10, p. 5066, doi. 10.1002/cam4.1730
- By:
- Publication type:
- Article
p85 Protein Expression is Associated with Poor Survival in HER2-Positive Patients with Advanced Breast Cancer Treated with Trastuzumab.
- Published in:
- Pathology & Oncology Research, 2015, v. 21, n. 2, p. 273, doi. 10.1007/s12253-014-9818-2
- By:
- Publication type:
- Article
Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia.
- Published in:
- Molecular & Clinical Oncology, 2016, v. 4, n. 2, p. 211, doi. 10.3892/mco.2015.693
- By:
- Publication type:
- Article
Tumor Mutational Patterns and Infiltrating Lymphocyte Density in Young and Elderly Patients With Breast Cancer.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2020, v. 17, n. 2, p. 181, doi. 10.21873/cgp.20179
- By:
- Publication type:
- Article
Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The Prognostic Role of Ephrin A2 and Endothelia Growth Factor Receptor Pathway Mediators in Patients With Advanced Colorectal Cancer Treated With Cetuximab.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 267, doi. 10.1016/j.clcc.2013.07.001
- By:
- Publication type:
- Article
PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1289, doi. 10.1007/s00280-015-2762-3
- By:
- Publication type:
- Article
Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).
- Published in:
- Annals of Gastroenterology, 2016, v. 29, n. 4, p. 390, doi. 10.20524/aog.2016.0050
- By:
- Publication type:
- Article
Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).
- Published in:
- Annals of Gastroenterology, 2016, v. 29, n. 2, p. 103, doi. 10.20524/aog.2016.0003
- By:
- Publication type:
- Article
Clinical practice guidelines for the surgical management of colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO.
- Published in:
- Annals of Gastroenterology, 2016, v. 29, n. 1, p. 3
- By:
- Publication type:
- Article
Adjuvant chemotherapy for colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO.
- Published in:
- Annals of Gastroenterology, 2016, v. 29, n. 1, p. 18
- By:
- Publication type:
- Article
Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164013
- By:
- Publication type:
- Article
Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0163138
- By:
- Publication type:
- Article
Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
- Published in:
- Journal of Translational Medicine, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12967-015-0530-0
- By:
- Publication type:
- Article
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab.
- Published in:
- Journal of Translational Medicine, 2012, v. 10, n. 1, p. 212, doi. 10.1186/1479-5876-10-212
- By:
- Publication type:
- Article
Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study.
- Published in:
- Gastric Cancer, 2006, v. 9, n. 1, p. 26, doi. 10.1007/s10120-005-0353-4
- By:
- Publication type:
- Article
Results of a prospective multicenter neuroendocrine tumor registry reporting on clinicopathologic characteristics of Greek patients.
- Published in:
- BMC Endocrine Disorders, 2016, v. 16, p. 1, doi. 10.1186/s12902-016-0089-7
- By:
- Publication type:
- Article
Weekly Docetaxel with or without Gemcitabine as Second-Line Chemotherapy in Paclitaxel-Pretreated Patients with Metastatic Breast Cancer: A Randomized Phase II Study Conducted by the Hellenic Co-Operative Oncology Group.
- Published in:
- Oncology, 2009, v. 77, n. 3/4, p. 212, doi. 10.1159/000236021
- By:
- Publication type:
- Article
Dose-Dense Adjuvant Chemotherapy with Epirubicin Monotherapy in Patients with Operable Breast Cancer and ≥10 Positive Axillary Lymph Nodes.
- Published in:
- Oncology, 1998, v. 55, n. 6, p. 508, doi. 10.1159/000011903
- By:
- Publication type:
- Article
Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence.
- Published in:
- Oncology Letters, 2022, v. 23, n. 4, p. N.PAG, doi. 10.3892/ol.2022.13235
- By:
- Publication type:
- Article
mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab.
- Published in:
- Oncology Letters, 2022, v. 23, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.
- Published in:
- PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0207707
- By:
- Publication type:
- Article
Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0200302
- By:
- Publication type:
- Article
A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: A Hellenic Cooperative Oncology Group study.
- Published in:
- BMC Medicine, 2011, v. 9, n. 1, p. 10, doi. 10.1186/1741-7015-9-10
- By:
- Publication type:
- Article
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.
- Published in:
- BMC Medicine, 2010, v. 8, p. 1, doi. 10.1186/1741-7015-8-3
- By:
- Publication type:
- Article
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1406-7
- By:
- Publication type:
- Article
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 384, doi. 10.1186/s12885-015-1406-7
- By:
- Publication type:
- Article
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-515
- By:
- Publication type:
- Article
Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 515, doi. 10.1186/1471-2407-14-515
- By:
- Publication type:
- Article
Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II study.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer.
- Published in:
- Medical Oncology, 2007, v. 24, n. 3, p. 301
- By:
- Publication type:
- Article
Protein expression patterns of cell cycle regulators in operable breast cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0180489
- By:
- Publication type:
- Article
A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-111
- By:
- Publication type:
- Article
A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).
- Published in:
- 2014
- By:
- Publication type:
- journal article